Vitamin C Transporters in the Brain
Vitamin C Transporters in the Brain
批准号:
8096657
负责人:
JAMES M. MAY
金额:
$29.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2013-06-30
关键词:
AffectAffinity LabelsAlzheimer&aposs DiseaseAnimalsAntioxidantsAscorbic AcidBirthBrainBrain DeathCellsCerebral hemisphere hemorrhageClinical ResearchCysteineDevelopmentElectrophysiology (science)EngineeringGlutamatesGoalsHealthHomeostasisHuntington DiseaseIn VitroInfarctionInjuryKnock-outKnockout MiceMembrane ProteinsModelingMusMutagenesisMyelinNervous System PhysiologyNeuraxisNeurodegenerative DisordersNeurologicNeuronsOxidantsOxidation-ReductionParkinson DiseasePeptidesProteinsRegulationReperfusion InjuryResistanceRoleStrokeStructure-Activity RelationshipSynapsesTestingTissuesToxic effectTransgenic MiceTransgenic OrganismsVitamin C in Brain PathwayVitamin E DeficiencyVitaminsXenopus oocyteaffinity labelingamidationascorbateextracellularhuman diseasein vivoneuroblastoma cellnoveloxidant stresspreventresponsesodium-dependent vitamin C transporter 2
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vitamin C, or ascorbic acid, has been shown in animal and clinical studies to help delay or prevent complications attributed to increased oxidant stress in stroke and in several neurodegenerative disorders. Normally, ascorbate is maintained at relatively high concentrations in brain and especially in neurons, where it serves as an antioxidant and supports several important neuronal functions. Ascorbate concentrations in the low millimolar range are generated in neurons by a specific ascorbate transporter, termed the SVCT2. Mice engineered to lack this transporter have very low brain ascorbate contents and die at birth with cerebral hemorrhage, indicating that the vitamin is crucial for survival. The overall goal of this proposal is to determine how the SVCT2 transporter is regulated in neurons, and whether changes in transporter number can affect neuronal function and antioxidant defenses, both in vitro and in vivo. There are three specific aims. In the first aim, mechanisms of SVCT2 regulation and structure-function relationships will be evaluated in cultured SH-SY5Y neuroblastoma cells and in Xenopus oocytes. Regulation of both SVCT2 expression and activity in response to oxidant stress will be assessed in SH-SY5Y cells. Further, the functional role of key cysteines on the extracellular surface of the protein will be evaluated by affinity labeling in SH- SY5Y cells and by mutagenesis approaches in Xenopus oocytes. In the second aim, the mechanism by which knock-out mice lacking the SVCT2 die at birth will be determined. Also in Aim 2, a novel model of oxidant stress due to combined deficiencies of vitamins E and C will be used to establish whether transgenic mice expressing increased amounts of SVCT2 are protected from neurologic damage compared to mice expressing normal or decreased (50%) SVCT2. In the third aim, primary culture neurons will be prepared from mice expressing several different levels of SVCT2 (transgenic, wild-type, heterozygous knock-out, and homozygous knock-out). These cells will be used to test whether SVCT2 expression 1) determines the ability of neurons to maintain intracellular ascorbate, 2) increases resistance of neurons to oxidant stress, 3) enhances maturation of cortical neurons in culture, and 3) affects neuronal electrophysiology. Results from these studies are expected to show that the SVCT2 ascorbate transporter, as regulated by oxidant stress, is crucial for neuronal function, development, and survival. PUBLIC HEALTH RELEVANCE: This project to study the function, regulation and tissue expression of the transporter for vitamin C in the brain has relevance for neuronal function, maturation and resistance to oxidant stress. Several neurodegenerative diseases including Alzheimer's and Parkinson's are associated with increased oxidant stress so that this project will help define the role of vitamin C in oxidant injury to the brain.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.brainres.2010.06.037
发表时间:
2010-08-19
期刊:
BRAIN RESEARCH
影响因子:
2.9
作者:
[Harrison, Fiona E., Meredith, M. Elizabeth, Dawes, Sean M., Saskowski, Jeanette L., May, James M.]
通讯作者:
May, James M.
DOI:
10.1016/j.brainres.2010.05.090
发表时间:
2010-08-12
期刊:
BRAIN RESEARCH
影响因子:
2.9
作者:
[Harrison, Fiona E., Green, Roslyn J., Dawes, Sean M., May, James M.]
通讯作者:
May, James M.
Behavioral and monoamine changes following severe vitamin C deficiency.
严重的维生素C缺乏后,行为和单胺变化。
DOI:
10.1111/jnc.12069
发表时间:
2013-02
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Ward MS, Lamb J, May JM, Harrison FE]
通讯作者:
Harrison FE
DOI:
10.1016/j.bbrc.2011.09.146
发表时间:
2011-11-04
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Meredith, M. Elizabeth, Harrison, Fiona E., May, James M.]
通讯作者:
May, James M.
DOI:
10.1016/j.freeradbiomed.2011.02.006
发表时间:
2011-05-01
期刊:
FREE RADICAL BIOLOGY AND MEDICINE
影响因子:
7.4
作者:
[Qiao, Huan, May, James M.]
通讯作者:
May, James M.
Failure of the glutamate uptake-ascorbic acid exchange drives seizure susceptibility and severity
-
批准号:9892973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:JAMES M. MAY
-
依托单位:
Failure of the glutamate uptake-ascorbic acid exchange drives seizure susceptibility and severity
-
批准号:9352655
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:JAMES M. MAY
-
依托单位:
Failure of the glutamate uptake-ascorbic acid exchange drives seizure susceptibility and severity
-
批准号:10683056
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:JAMES M. MAY
-
依托单位:
Failure of the glutamate uptake-ascorbic acid exchange drives seizure susceptibility and severity
-
批准号:10179345
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:JAMES M. MAY
-
依托单位:
Ascorbic Acid Function and Metabolism
-
批准号:7899389
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:JAMES M. MAY
-
依托单位:
Vitamin C Transporters in the Brain
-
批准号:7526762
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2008
-
负责人:JAMES M. MAY
-
依托单位:
Vitamin C Transporters in the Brain
-
批准号:7624264
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2008
-
负责人:JAMES M. MAY
-
依托单位:
Vitamin C Transporters in the Brain
-
批准号:7860690
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2008
-
负责人:JAMES M. MAY
-
依托单位:
ANITOXIDANT FUNCTIONS OF LIPOIC ACID
-
批准号:7605547
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2006
-
负责人:JAMES M. MAY
-
依托单位:
ANITOXIDANT FUNCTIONS OF LIPOIC ACID
-
批准号:7731372
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2006
-
负责人:JAMES M. MAY
-
依托单位:
ANITOXIDANT FUNCTIONS OF LIPOIC ACID
-
批准号:7375606
-
项目类别:
-
资助金额:$1.22万
-
财政年份:2005
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant vitamins in models of Alzheimer's Disease
-
批准号:6989030
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant vitamins in models of Alzheimer's Disease
-
批准号:7365159
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant vitamins in models of Alzheimer's Disease
-
批准号:6718831
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant vitamins in models of Alzheimer's Disease
-
批准号:7173812
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant vitamins in models of Alzheimer's Disease
-
批准号:6843098
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
ANITOXIDANT FUNCTIONS OF LIPOIC ACID
-
批准号:7207242
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2004
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant Functions of Lipoic Acid
-
批准号:6685423
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2003
-
负责人:JAMES M. MAY
-
依托单位:
Antioxidant Functions of Lipoic Acid
-
批准号:6772529
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2003
-
负责人:JAMES M. MAY
-
依托单位:
ANTIOXIDANT INTERACTIONS OF SELENIUM AND VITAMINS
-
批准号:6124018
-
项目类别:
-
资助金额:$26.99万
-
财政年份:1998
-
负责人:JAMES M. MAY
-
依托单位:
海外基金